{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-045250","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2022-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.071842+00:00","generated_at":"2026-06-26T07:42:23.595169+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Elanco spins out microbiome platform into BiomEdit with $40M funding; tenders $406M of 2023 notes","bullets":["Elanco launches BiomEdit, a microbiome innovation company, with $40M Series A from Viking Global and Anterra Capital.","Elanco contributes IP and pipeline to BiomEdit; retains non-voting equity; combined Elanco/Ginkgo ownership ~40% fully diluted.","Tender offer: $406M (54.19%) of 4.272% notes due 2023 tendered; cap raised to $406M; early acceptance at $1,035 per $1,000.","BiomEdit to leverage Ginkgo's cell programming platform for probiotics, bioactives, and engineered microbial medicines.","Aaron Schacht named CEO of BiomEdit; enters consulting agreement with Elanco at $250/hour for advisory role."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-045250","json":"https://secwatch.observer/filing/0001104659-22-045250.json","markdown":"https://secwatch.observer/filing/0001104659-22-045250.md","text":"https://secwatch.observer/filing/0001104659-22-045250.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000110465922045250/0001104659-22-045250-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000110465922045250/tm2212574d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:42:23.595169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}